Decreased expression of vesicular glutamate transporter 1 and complexin II mRNAs in schizophrenia: Further evidence for a synaptic pathology affecting glutamate neurons

Schizophrenia Research

Volumn 73, Issue 2-3, 2005, Pages 159-172

  Eastwood, S L ^a   Harrison, P J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Gene expression; Hippocampus; In situ hybridization; Neuropathology; Prefrontal cortex; Synaptic protein

Indexed keywords

COMPLEXIN I; COMPLEXIN II; GLUTAMIC ACID; MESSENGER RNA; PROTEIN DERIVATIVE; UNCLASSIFIED DRUG; VESICULAR GLUTAMATE TRANSPORTER 1; VESICULAR GLUTAMATE TRANSPORTER 2;

ADULT; AGED; ARTICLE; BRAIN NERVE CELL; CONTROLLED STUDY; FEMALE; FRONTAL CORTEX; HIPPOCAMPUS; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MALE; NUCLEOTIDE SEQUENCE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; SCHIZOPHRENIA; SYNAPSE; SYNAPTIC TRANSMISSION; TEMPORAL CORTEX;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENE EXPRESSION; GLUTAMIC ACID; HIPPOCAMPUS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; NEURONS; PREFRONTAL CORTEX; RNA, MESSENGER; SCHIZOPHRENIA; SYNAPSES; SYNAPTIC TRANSMISSION; TEMPORAL LOBE; VESICULAR GLUTAMATE TRANSPORT PROTEIN 1; VESICULAR GLUTAMATE TRANSPORT PROTEIN 2;

EID: 11844304923     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2004.05.010     Document Type: Article

References (94)

1. S. Akbarian, J.J. Kim, S.G. Potkin, J.O. Hagman, A. Tafazzoli, W.E. Bunney Jr., and E.G. Jones Gene expression for glutamic acid carboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics Arch. Gen. Psychiatry 52 1995 258 266
2. L. Bai, H. Xu, J.F. Collins, and F.K. Ghishan Molecular and functional analysis of a novel neuronal vesicular glutamate transporter J. Biol. Chem. 276 2001 36764 36769
3. A.J.L. Barton, A. Najlerahim, R.C.A. Pearson, and P.J. Harrison Pre- and postmortem influences on brain RNA J. Neurochem. 61 1993 1 11
4. G. Bartzokis Schizophrenia: breakdown in the well-regulated lifelong process of brain development and maturation Neuropsychopharmacology 27 2002 672 683
5. C.L. Beasley, Z.J. Zhang, I. Patten, and G.P. Reynolds Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins Biol. Psychiatry 52 2002 708 715
6. E.E. Bellochio, H. Hu, A. Pohorille, J. Chan, V.M. Pickel, and R.H. Edwards The localization of the brain-specific inorganic phosphate transporter suggests a presynaptic role in glutamatergic neurotransmission J. Neurosci. 18 1998 638 8659
7. E.E. Bellochio, R.J. Reimer, R.T. Fremeau Jr., and R.H. Edwards Uptake of glutamate into synaptic vesicles by an inorganic phosphate transporter Science 289 2000 957 960
8. F.M. Benes, and S. Berretta GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder Neuropsychopharmacology 25 2001 1 27
9. F.M. Benes, J. McSparren, E. Bird, J. SanGiovanni, and S.L. Vincent Deficits in small interneurons in pre-frontal and cingulate cortices of schizophrenic and schizoaffective patients Arch. Gen. Psychiatry 48 1991 996 1001
10. M.D. Browning, E.M. Dudek, J.L. Rapier, S. Leonard, and R. Freedman Significant reductions in synapsin but not synaptophysin specific activity in the brains of some schizophrenics Biol. Psychiatry 34 1993 529 535
11. 2A receptor mRNAs and binding site densities are differentially affected in schizophrenia Neuropsychopharmacology 15 1996 442 455
12. P. Davidsson, J. Gottfries, N. Bogdanovic, R. Ekman, I. Karlsson, C.-G. Gottfries, and K. Blennow The synaptic-vesicle-specific proteins rab3a and synaptophysin are reduced in thalamus and related cortical brain regions in schizophrenic brains Schizophr. Res. 40 1999 23 29
13. L. DeLisi Is schizophrenia a lifetime disorder of brain plasticity, growth and aging? Schizophr. Res. 23 1997 119 129
14. S.L. Eastwood The synaptic pathology of schizophrenia: is aberrant neurodevelopment and plasticity to blame? J. Smythies Disorders of Synaptic Plasticity and Schizophrenia International Reviews of Neurobiology vol. 59 2004 Elsevier Amsterdam 47 72
15. S.L. Eastwood, and P.J. Harrison Decreased synaptophysin in the medial temporal lobe in schizophrenia demonstrated using immunoautoradiography Neuroscience 69 1995 339 343
16. S.L. Eastwood, and P.J. Harrison Hippocampal and cortical growth-associated protein-43 messenger RNA in schizophrenia Neuroscience 86 1998 437 448
17. S.L. Eastwood, and P.J. Harrison Detection and quantification of hippocampal synaptophysin messenger RNA in schizophrenia using autoclaved, formalin-fixed, paraffin wax-embedded sections Neuroscience 93 1999 99 106
18. S.L. Eastwood, and P.J. Harrison Hippocampal synaptic pathology in schizophrenia bipolar disorder and major depression: a study of complexin mRNAs Mol. Psychiatry 5 2000 425 432
19. S.L. Eastwood, and P.J. Harrison Synaptic pathology in the anterior cingulate cortex in schizophrenia and mood disorders. A review and a western blot study of synaptophysin, GAP-43 and the complexins Brain Res. Bull. 55 2001 569 578
20. S.L. Eastwood, and P.J. Harrison Interstitial white matter neurons express less reelin and are abnormally distributed in schizophrenia: towards an integration of molecular and morphologic aspects of the neurodevelopmental hypothesis Mol. Psychiatry 8 2003 821 831
21. S.L. Eastwood, P.W.J. Burnet, and P.J. Harrison Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia Neuroscience 66 1995 309 319
22. S.L. Eastwood, B. McDonald, P.W.J. Burnet, J.P. Beckwith, R.W. Kerwin, and P.J. Harrison Decreased expression of mRNAs encoding non-NMDA glutamate receptors GluR1 and GluR2 in medial temporal lobe neurons in schizophrenia Mol. Brain Res. 29 1995 211 223
23. S.L. Eastwood, J. Heffernan, and P.J. Harrison Chronic haloperidol differentially affects the expression of synaptic and neuronal plasticity-associated genes Mol. Psychiatry 2 1997 322 329
24. S.L. Eastwood, N.J. Cairns, and P.J. Harrison Synaptophysin gene expression in schizophrenia: investigation of synaptic pathology in the cerebral cortex Br. J. Psychiatry 176 2000 236 242
25. S.L. Eastwood, P.W.J. Burnet, and P.J. Harrison Expression of complexin I and II mRNAs and their regulation by antipsychotic drugs in the rat forebrain Synapse 36 2000 167 177
26. S.L. Eastwood, D. Cotter, and P.J. Harrison Cerebellar synaptic protein expression in schizophrenia Neuroscience 105 2001 219 229
27. S.L. Eastwood, A.J. Law, I.P. Everall, and P.J. Harrison The axonal chemorepellant semaphorin 3A is increased in the cerebellum in schizophrenia and may contribute to its synaptic pathology Mol. Psychiatry 8 2003 148 155
28. S.H. Fatemi, J.A. Earle, J. Stary, S. Lee, and J. Sedgwick Altered levels of the synaptosome associated protein SNAP-25 in hippocampus of subjects with mood disorders and schizophrenia NeuroReport 12 2001 3257 3262
29. W.G. Frankle, J. Lerma, and M. Laruelle The synaptic hypothesis of schizophrenia Neuron 39 2003 205 216
30. R.T. Fremeau Jr., M.D. Troyer, I. Pahner, G.O. Nygaard, C.H. Tran, R.J. Reimer, E.E. Bellochio, D. Fortin, J. Storm-Mathisen, and R.H. Edwards The expression of vesicular glutamate transporters defines two classes of excitatory synapse Neuron 31 2001 247 260
31. A. Guidotti, J. Auta, J.M. Davis, V.D. Gerevini, Y. Dwivedi, D.R. Grayson, F. Impagniatello, G. Pandey, C. Pesold, R. Sharma, D. Uzunov, and E. Costa Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder-a postmortem brain study Arch. Gen. Psychiatry 57 2000 1061 1069
32. P.J. Harrison The neuropathology of schizophrenia. A critical review of the data and their interpretation Brain 122 1999 593 624
33. P.J. Harrison The neuropathological effects of antipsychotic drugs Schizophr. Res. 40 1999 87 99
34. P.J. Harrison The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications Psychopharmacology 174 2004 151 162
35. P.J. Harrison, and S.L. Eastwood Preferential involvement of excitatory neurons in medial temporal lobe in schizophrenia Lancet 352 1998 1669 1673
36. P.J. Harrison, and S.L. Eastwood Neuropathological studies of synaptic connectivity in the hippocampal formation in schizophrenia Hippocampus 11 2001 508 519
37. P.J. Harrison, and M.J. Owen Genes for schizophrenia? Recent findings and their pathophysiological implications Lancet 361 2003 417 419
38. P.J. Harrison, P.R. Heath, S.L. Eastwood, P.W.J. Burnet, B. McDonald, and R.C.A. Pearson The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: selective mRNA vulnerability and comparison with their encoded proteins Neurosci. Lett. 200 1995 151 154
39. P.J. Harrison, P.W.J. Burnet, P. Falkai, B. Bogerts, and S.L. Eastwood Gene expression and neuronal activity in schizophrenia: a study of polyadenylated mRNA in the hippocampal formation and cerebral cortex Schizophr. Res. 26 1997 93 102
40. P.J. Harrison, A.J. Law, and S.L. Eastwood Glutamate receptors and transporters in the hippocampus in schizophrenia Ann. N.Y. Acad. Sci. 1003 2003 94 101
41. P.D. Harvey, J.M. Silverman, R.C. Mohs, M. Parrella, L. White, P. Powchik, M. Davidson, and K.L. Davis Cognitive decline in late-life schizophrenia: a longitudinal study of geriatric chronically hospitalized patients Biol. Psychiatry 45 1999 32 40
42. J.M. Heffernan, S.L. Eastwood, Z. Nagy, M.W. Sanders, B. McDonald, and P.J. Harrison Temporal cortex synaptophysin mRNA is reduced in Alzheimer's disease and is negatively correlated with the severity of dementia Exp. Neurol. 150 1998 235 239
43. S.E. Hemby, S.D. Ginsberg, B. Brunk, S.E. Arnold, J.Q. Trojanowski, and J.H. Eberwine Gene expression profile for schizophrenia-discrete neuron transcription patterns in the entorhinal cortex Arch. Gen. Psychiatry 59 2002 631 640
44. E. Herzog, G.C. Bellenchi, C. Gras, V. Bernard, P. Ravassard, C. Bedet, B. Gasnier, B. Giros, and S. El Mistikawy The existence of a second vesicular glutamate transporter specified subpopulations of glutamatergic neurons J. Neurosci. 21 2001 1 6
45. D.P. Holinger, A.M. Galaburda, and P.J. Harrison Cerebral asymmetry P.J. Harrison G.W. Roberts The Neuropathology of Schizophrenia. Progress and Interpretation 2000 Oxford Univ. Press Oxford 151 172
46. W.G. Honer Pathology of presynaptic proteins in Alzheimer's disease: more than simple loss of terminals Neurobiol. Aging 8 2003 1047 1062
47. W.G. Honer, and C.E. Young Presynaptic proteins and schizophrenia J. Smythies Disorders of Synaptic Plasticity and Schizophrenia International Reviews of Neurobiology vol. 59 2003 Elsevier Amsterdam 175 199
48. W.G Honer, C. Young, and P. Falkai Synaptic pathology P.J. Harrison G.W. Roberts The Neuropathology of Schizophrenia. Progress and Interpretation 2000 Oxford Univ. Press Oxford 105 136
49. T. Kaneko, F. Fujiuyama, and H. Hioke Immunohistochemical localization of candidates for vesicular glutamate transporters in the rat brain J. Comp. Neurol. 444 2002 39 62
50. C.N. Karson, R.E. Mrak, K.O. Schluterman, W.Q. Sturner, J.G. Sheng, and W.S.T. Griffin Alterations in synaptic proteins and their encoding mRNAs in prefrontal cortex in schizophrenia: a possible basis for 'hypofrontality' Mol. Psychiatry 4 1999 39 45
51. M.S. Keshavan, S. Anderson, and J.W. Pettegrew Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex-the Feinberg hypothesis revisited J. Psychiat. Res. 23 1993 239 265
52. C. Konradi, and S. Heckers Antipsychotic drugs and neuroplasticity: insights into the treatment and neurobiology of schizophrenia Biol. Psychiatry 50 2001 729 742
53. C. Konradi, and S. Heckers Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment Pharmacol. Ther. 97 2003 153 179
54. A.J. Law, C.S. Weickert, T.M. Hyde, J.E. Kleinman, and P.J. Harrison Reduced spinophilin but not MAP2 expression in the hippocampal formation in schizophrenia and mood disorder: molecular evidence for a pathology of dendritic spines Am. J. Psychiatry 2004 (in press)
55. D.A. Lewis, J.N. Pierri, D.W. Volk, D.S. Melchitzky, and T.U. Woo Altered GABA neurotransmission and prefrontal cortical dysfunction in schizophrenia Biol. Psychiatry 46 1999 616 626
56. D.A. Lewis, D.A. Cruz, D.S. Melchitzky, and J.N. Pierri Lamina-specific deficits in parvalbumin-immunoreactive varicosities in the prefrontal cortex of subjects with schizophrenia: evidence for fewer projections from the thalamus Am. J. Psychiatry 158 2001 1411 1422
57. A.M. Lipton, C. Cullum, S. Satumtira, E. Sontag, L. Hynan, C.L. White, and E. Bigio Contribution of asymmetric synapse loss to lateralizing clinical deficits in frontotemporal dementias Ann. Neurol. 58 2001 1233 1239
58. R.K. McClure, and J.A. Lieberman Neurodevelopmental and neurodegenerative hypotheses of schizophrenia: a review and critique Curr. Opin. Psychiatry 16 Suppl. 2 2003 S15 S28
59. R.E. McCullumsmith, and J.H. Meador-Woodruff Expression of vesicular glutamate transporters one and two in medial temporal lobe structures in schizophrenia bipolar disorder, and major depressive disorder [Abstract] Schizophr. Res. 60 2003 65 (suppl.)
60. T.H. McGlashan, and R.E. Hoffman Schizophrenia as a disorder of developmentally reduced synaptic connectivity Arch. Gen. Psychiatry 57 2000 637 648
61. J.H. Meador-Woodruff, and D.J. Healy Glutamate receptor expression in schizophrenic brain Brain Res. Rev. 31 2000 288 294
62. K. Mirnics, F.A. Middleton, D.A. Lewis, and P. Levitt Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse Trends Neurosci. 24 2001 479 486
63. H.W. Moises, T. Zoega, and I. Gottesman The glial growth factors deficiency and synaptic destabilization hypothesis of schizophrenia BMC Psychiatry 2 2002 (www.biomedcentral.com/1471-244X/2/8)
64. R. Morimoto, M. Hayashi, S. Yatsushiro, M. Otsuka, A. Yamamoto, and Y. Moriyama Co-expression of vesicular glutamate transporters (VGLUT1 and VGLUT2) and their association with synaptic-like microvesicles in rat pinealocytes J. Neurochem. 84 2003 382 391
65. E.B. Mukaetvoa-Ladinska, J. Hurt, W.G. Honer, C.R. Harrington, and C.M. Wischik Loss of synaptic but not cytoskeletal proteins in the cerebellum of chronic schizophrenics Neurosci. Lett. 317 2002 161 165
66. T. Nakahara, K. Motomura, K. Hashimoto, H. Ueki, L. Goto, H. Hondo, T. Tsutsumi, T. Kuroki, M. Hirano, and H. Uchimura Long-term treatment with haloperidol decreases the mRNA levels of complexin I, but not complexin II, in rat prefrontal cortex, nucleus accumbens and ventral tegmental area Neurosci. Lett. 290 2000 29 32
67. G. Novak, D. Kim, P. Seeman, and T. Tallerico Schizophrenia and Nogo: elevated mRNA in cortex, and high prevalence of a homozygous CAA insert Mol. Brain Res. 107 2002 183 189
68. C. Nowakowski, W.A. Kaufmann, C. Adlassnig, H. Maier, K. Salimi, K.A. Jellinger, and J. Marksteiner Reduction of chromogranin B-like immunoreactivity in distinct subregions of the hippocampus from individuals with schizophrenia Schizophr. Res. 58 2002 43 53
69. T. Ohnuma, S.J. Augood, H. Arai, P.J. McKenna, and P.C. Emson Measurement of GABAergic parameters in the prefrontal cortex in schizophrenia: focus on GABA content GABA(A) receptor alpha-1 subunit messenger RNA and human GABA transporter-1 (HGAT-1) messenger RNA expression Neuroscience 93 1999 441 448
70. P. Preece, and N.J. Cairns Quantifying mRNA in postmortem human brain: influence of gender, age at death, postmortem interval, brain pH, agonal state and inter-lobe mRNA variance Mol. Brain Res. 118 2003 60 71
71. G. Rosoklija, G. Toomayan, S.P. Ellis, J. Keilp, J.J. Mann, N. Latov, A.P. Hays, and A.J. Dwork Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders-preliminary findings Arch. Gen. Psychiatry 57 2000 349 356
72. K. Sawada, C.E. Young, A.M. Barr, K. Longworth, S. Takahashi, V. Arango, J.J. Mann, A.J. Dwork, P. Falkai, A.G. Phillips, and W.G. Honer Altered immunoreactivity of complexin protein in prefrontal cortex in severe mental illness Mol. Psychiatry 7 2002 484 492
73. K. Sawada, A.M. Barr, S. Takahashi, K. Arima, P. Falkai, A. Phillips, and W.G. Honer Complexins I and II in hippocampus in schizophrenia [Abstract] Schizophr. Res. 60 2003 74 75 (suppl.)
74. R.E. Smith, V. Haroutunian, K.L. Davis, and J.H. Meador-Woodruff Vesicular glutamate transporter transcript expression in the thalamus in schizophrenia NeuroReport 12 2001 2885 2887
75. B.P. Sokolov, A.A. Tcherepanov, V. Haroutunian, and K.L. Davis Levels of mRNAs encoding synaptic vesicle and synaptic plasma membrain proteins in the temporal cortex of elderly schizophrenic patients Biol. Psychiatry 48 2000 184 196
76. T.C. Südhof The synaptic vesicle cascade: a cascade of protein-protein interactions Nature 375 1995 645 653
77. T.C. Südhof The synaptic vesicle cycle Annu. Rev. Neurosci. 27 2004 509 547
78. S. Takahashi, H. Yamamoto, Z. Matsuda, M. Ogawa, K. Yagyu, T. Taniguchi, T. Miyata, H. Kaba, T. Higuchi, F. Okutani, and S. Fujimoto Identification of two highly homologous presynaptic proteins distinctly localised at the dendritic and somatic synapses FEBS Lett. 368 1995 455 460
79. S. Takahashi, H. Ujihara, G.Z. Huang, K. Yagyu, M. Sanbo, H. Kaba, and T. Yagi Reduced hippocampal LTP in mice lacking a presynaptic protein, complexin II Eur. J. Neurosci. 11 1999 2359 2366
80. K. Talbot, W.L. Eidem, C.L. Tinsley, M.A. Benson, E.W. Thompson, R.J. Smith, C.-G. Hahn, S.J. Siegel, J.Q. Trojanowski, R.E. Gur, D.J. Blake, and S.E. Arnold Dysbindin-1 is reduced in intrinsic glutamatergic terminals of the hippocampal formation in schizophrenia J. Clin. Invest. 113 2004 1353 1363
81. A.A. Tcherepanov, and B.P. Sokolov Age-related abnormalities in expression of mRNAs encoding synapsin 1A, synapsin 1B, and synaptophysin in the temporal cortex of schizophrenics J. Neurosci. 49 1997 639 644
82. R.D. Terry, E. Masliah, D.P. Salmon, N. Butters, R. DeTeresa, R. Hill, L.A. Hanser, and R. Katzman Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment Ann. Neurol. 30 1991 572 580
83. P.M. Thompson, S. Egbufoama, and M.P. Vawter SNAP-25 reduction in the hippocampus of patients with schizophrenia Prog. Neuro-Psychopharmacol. Biol. Psychiatry 27 2003 411 417
84. 1 transporter as a novel vesicular glutamate transporter expressed in a distinct set of glutamatergic synapses J. Neurosci. 22 2002 142 155
85. M.P. Vawter, L. Thatcher, N. Usen, T.M. Hyde, J.E. Kleinman, and W.J. Freed Reduction of synapsin in the hippocampus of patients with bipolar disorder and schizophrenia Mol. Psychiatry 7 2002 571 579
86. C. Verderio, D. Pozzi, E. Pravettoni, F. Inverardi, U. Schenk, S. Coco, V. Proux-Gillardeaux, T. Galli, O. Rossetto, C. Frassoni, and M. Matteoli SNAP-25 modulation of calcium dynamics underlies differences in GABAergic and glutamatergic responsiveness to depolarization Neuron 41 2004 599 610
87. D. Volk, M. Austin, J. Pierri, A. Sampson, and D. Lewis GABA transporter-1 mRNA in the prefrontal cortex in schizophrenia: decreased expression in a subset of neurons Am. J. Psychiatry 158 2001 256 265
88. M.J. Webster, C.S. Weickert, M.M. Herman, T.M. Hyde, and J.E. Kleinman Synaptophysin and GAP-43 mRNA levels in the hippocampus of subjects with schizophrenia Schizophr. Res. 49 2001 89 98
89. D.R. Weinberger From neuropathology to neurodevelopment Lancet 346 1995 552 557
90. D.R. Weinberger Cell biology of the hippocampal formation in schizophrenia Biol. Psychiatry 45 1999 395 402
91. S.M. Wojcik, J.S. Rhee, E. Herzog, A. Sigler, R. Jahn, S. Takamori, N. Brose, and C. Rosenmund An essential role for vesicular glutamate transporter 1 (VGLUT1) in postnatal development and quantal size Proc. Natl. Acad. Sci. U. S. A. 101 2004 7158 7163
92. T.U. Woo, R.E. Whitehead, D.S. Melchitsky, and D.A. Lewis A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia Proc. Natl. Acad. Sci. U. S. A. 95 1998 5341 5346
93. C.E. Young, K. Arima, J. Xie, L. Hu, T.G. Beach, P. Falkai, and W.G. Honer SNAP-25 deficit and hippocampal connectivity in schizophrenia Cereb. Cortex 8 1998 261 268
94. Z.J. Zhang, and G.P. Reynolds A selective decrease in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia Schizophr. Res. 55 2002 1 10